{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T01:51:25Z","timestamp":1783389085617,"version":"3.54.6"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"S4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1186\/s12859-019-2687-7","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T09:07:39Z","timestamp":1555578459000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Alexander","family":"Kel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulyana","family":"Boyarskikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Stegmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid S.","family":"Leskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrey V.","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Yevshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Mandrik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Stelmashenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Koschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kel-Margoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Krull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Mart\u00ednez-Card\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Esteller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor","family":"Kolpakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim","family":"Filipenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Wingender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,18]]},"reference":[{"key":"2687_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1586\/erm.10.17","volume":"10","author":"VV Levenson","year":"2010","unstructured":"Levenson VV. DNA methylation as a universal biomarker. Expert Rev Mol Diagn. 2010;10:481\u20138.","journal-title":"Expert Rev Mol Diagn"},{"key":"2687_CR2","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1530\/ERC-15-0369","volume":"23","author":"K Warton","year":"2016","unstructured":"Warton K, Mahon KL, Samimi G. Methylated circulating tumor DNA in blood: power in cancer prognosis and response. Endocr Relat Cancer. 2016;23:R157\u201371.","journal-title":"Endocr Relat Cancer"},{"key":"2687_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.3390\/genes5030821","volume":"5","author":"T Mikeska","year":"2014","unstructured":"Mikeska T, Craig JM. DNA methylation biomarkers: Cancer and beyond. Genes (Basel). 2014;5:821\u201364.","journal-title":"Genes (Basel)"},{"key":"2687_CR4","unstructured":"International Cancer Genome Consortium. \n                    http:\/\/icgc.org\/\n                    \n                  . Accessed 30 Nov 2018."},{"key":"2687_CR5","unstructured":"Systems Biology of Colorectal cancer; \n                    http:\/\/syscol-project.eu\/\n                    \n                  . Accessed 30 Nov 2018."},{"key":"2687_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nature13602","volume":"512","author":"H Ongen","year":"2014","unstructured":"Ongen H, Andersen CL, Bramsen JB, Oster B, Rasmussen MH, Ferreira PG, Sandoval J, Vidal E, Whiffin N, Planchon A, Padioleau I, Bielser D, Romano L, Tomlinson I, Houlston RS, Esteller M, Orntoft TF, Dermitzakis ET. Putative cis-regulatory drivers in colorectal cancer. Nature. 2014;512:87\u201390.","journal-title":"Nature"},{"key":"2687_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.2217\/bmm.14.8","volume":"8","author":"Y Li","year":"2014","unstructured":"Li Y, Song L, Gong Y, He B. Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future. Biomark Med. 2014;8:755\u201369.","journal-title":"Biomark Med"},{"key":"2687_CR8","doi-asserted-by":"publisher","first-page":"eaaj2239","DOI":"10.1126\/science.aaj2239","volume":"356","author":"Y Yin","year":"2017","unstructured":"Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Sayeed S, Das PK, Kivioja T, Dave K, Zhong F, Nitta KR, Taipale M, Popov A, Ginno PA, Domcke S, Yan J, Sch\u00fcbeler D, Vinson C, Taipale J. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science. 2017;356:eaaj2239.","journal-title":"Science"},{"key":"2687_CR9","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.celrep.2017.04.045","volume":"19","author":"JB Bramsen","year":"2017","unstructured":"Bramsen JB, Rasmussen MH, Ongen H, Mattesen TB, \u00d8rntoft MW, \u00c1rnad\u00f3ttir SS, Sandoval J, Laguna T, Vang S, \u00d8ster B, Lamy P, Madsen MR, Laurberg S, Esteller M, Dermitzakis ET, \u00d8rntoft TF, Andersen CL. Molecular-subtype-specific biomarkers improve prediction of prognosis in colorectal Cancer. Cell Rep. 2017;19:1268\u201380.","journal-title":"Cell Rep"},{"key":"2687_CR10","unstructured":"Bioconductor. \n                    www.bioconductor.org\n                    \n                  . Accessed 30 Nov 2018."},{"key":"2687_CR11","unstructured":"Galaxy. \n                    usegalaxy.org\n                    \n                  . Accessed 30 Nov 2018."},{"key":"2687_CR12","unstructured":"geneXplain platform. \n                    http:\/\/www.genexplain.com\n                    \n                  . Accessed 30 Nov 2018."},{"issue":"Suppl 2","key":"2687_CR13","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1186\/1471-2105-7-S2-S13","volume":"7","author":"A Kel","year":"2006","unstructured":"Kel A, Voss N, Jauregui R, Kel-Margoulis O, Wingender E. Beyond microarrays: find key transcription factors controlling signal transduction pathways. BMC Bioinformatics. 2006;7(Suppl 2):S13.","journal-title":"BMC Bioinformatics"},{"key":"2687_CR14","doi-asserted-by":"publisher","first-page":"D108","DOI":"10.1093\/nar\/gkj143","volume":"34","author":"V Matys","year":"2006","unstructured":"Matys V, Kel-Margoulis OV, Fricke E, Liebich I, Land S, Barre-Dirrie A, Reuter I, Chekmenev D, Krull M, Hornischer K, Voss N, Stegmaier P, Lewicki-Potapov B, Saxel H, Kel AE, Wingender E. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in ukaryotes. Nucleic Acids Res. 2006;34:D108\u201310.","journal-title":"Nucleic Acids Res"},{"key":"2687_CR15","unstructured":"TRANSFAC\u00ae database. \n                    http:\/\/genexplain.com\/transfac\n                    \n                  . Accessed 30 Nov 2018."},{"issue":"Web Server issu","key":"2687_CR16","doi-asserted-by":"publisher","first-page":"W541","DOI":"10.1093\/nar\/gkl342","volume":"34","author":"T Waleev","year":"2006","unstructured":"Waleev T, Shtokalo D, Konovalova T, Voss N, Cheremushkin E, Stegmaier P, Kel-Margoulis O, Wingender E, Kel A. Composite module analyst: identification of transcription factor binding site combinations using genetic algorithm. Nucleic Acids Res. 2006;34(Web Server issue):W541\u20135.","journal-title":"Nucleic Acids Res"},{"issue":"Suppl 1","key":"2687_CR17","first-page":"12","volume":"11","author":"U Boyarskikh","year":"2018","unstructured":"Boyarskikh U, Pintus S, Mandrik N, Stelmashenko D, Kiselev I, Evshin I, Sharipov R, Stegmaier P, Kolpakov F, Filipenko M, Kel A. Computational master-regulator search reveals mTOR and PI3K pathways responsible for low sensitivity of NCI-H292 and A427 lung cancer cell lines to cytotoxic action of p53 activator Nutlin-3. BMC Med Genet. 2018;11(Suppl 1):12.","journal-title":"BMC Med Genet"},{"key":"2687_CR18","doi-asserted-by":"publisher","first-page":"D546","DOI":"10.1093\/nar\/gkj107","volume":"34","author":"M Krull","year":"2006","unstructured":"Krull M, Pistor S, Voss N, Kel A, Reuter I, Kronenberg D, Michael H, Schwarzer K, Potapov A, Choi C, Kel-Margoulis O, Wingender E. TRANSPATH: an information resource for storing and visualizing signaling pathways and their pathological aberrations. Nucleic Acids Res. 2006;34:D546\u201351.","journal-title":"Nucleic Acids Res"},{"key":"2687_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euprot.2016.09.002","volume":"13","author":"AE Kel","year":"2016","unstructured":"Kel AE, Stegmaier P, Valeev T, Koschmann J, Poroikov V, Kel-Margoulis OV, Wingender E. Multi-omics \u201cupstream analysis\u201d of regulatory genomic regions helps identifying targets against methotrexate resistance of colon cancer. EuPA Open Proteomics. 2016;13:1\u201313.","journal-title":"EuPA Open Proteomics"},{"key":"2687_CR20","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1471-2164-15-119","volume":"15","author":"YA Medvedeva","year":"2014","unstructured":"Medvedeva YA, Khamis AM, Kulakovskiy IV, Ba-Alawi W, Bhuyan MS, Kawaji H, Lassmann T, Harbers M, Forrest AR, Bajic VB. FANTOM consortium. Effects of cytosine methylation on transcription factor binding sites. BMC Genomics. 2014;15:119.","journal-title":"BMC Genomics"},{"key":"2687_CR21","unstructured":"User interface for classification of the samples as CRC or non-CRC using as inputs the DNA methylation values of 6 biomarkers for one or more samples. \n                    http:\/\/micro.biouml.org\/bioumlweb\/#anonymous=true&perspective=DNA%20methylation%20signature%20for%20the%20diagnosis%20of%20colon%20cancer\n                    \n                  . Accessed 30 Nov 2018."},{"key":"2687_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/microarrays4020270","volume":"4","author":"J Koschmann","year":"2015","unstructured":"Koschmann J, Bhar A, Stegmaier P, Kel AE, Wingender E. \u201cUpstream analysis\u201d: an integrated promoter-pathway analysis approach to causal interpretation of microarray data. Microarrays. 2015;4:270\u201386.","journal-title":"Microarrays"},{"key":"2687_CR23","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.1093\/nar\/gkw521","volume":"44","author":"M Siebert","year":"2016","unstructured":"Siebert M, S\u00f6ding J. Markov models consistently outperform PWMs atpredicting regulatory motifs in nucleotide sequences. Nucleic Acids Res. 2016;44:6055\u201369.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2687_CR24","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2217\/epi-2015-0013","volume":"8","author":"Y Hashimoto","year":"2016","unstructured":"Hashimoto Y, Zumwalt TJ, Goel A. DNA methylation patterns as noninvasive biomarkers and targets of epigenetic therapies in colorectal cancer. Epigenomics. 2016;8(5):685\u2013703.","journal-title":"Epigenomics"},{"key":"2687_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0304-3835(01)00839-4","volume":"188","author":"H Nakayama","year":"2002","unstructured":"Nakayama H, Hibi K, Takase T, Yamazaki T, Kasai Y, Ito K, Akiyama S, Nakao A. Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett. 2002;188:115\u20139.","journal-title":"Cancer Lett"},{"key":"2687_CR26","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1373\/clinchem.2008.115808","volume":"55","author":"T deVos","year":"2009","unstructured":"deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Gr\u00fctzmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, Day R, Sledziewski AZ, Lofton-Day C. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem. 2009;55:1337\u201346.","journal-title":"Clin Chem"},{"key":"2687_CR27","unstructured":"Results of the analysis using the pipeline My-Genome-Enhancer in geneXplain platform. \n                    https:\/\/platform.genexplain.com\/bioumlweb\/#anonymous=true&de=data\/Projects\/CRC_6_CpG_biomarkers\/Data\/Table%20S10_list%20of%206%20biomarker%20combination\n                    \n                  . Accessed 30 Nov 2018."},{"key":"2687_CR28","unstructured":"The software tools and databases used are available on-line at URL. \n                    my-genome-enhancer.com\n                    \n                  . Accessed 30 Nov 2018."}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12859-019-2687-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12859-019-2687-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T23:07:53Z","timestamp":1587078473000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/s12859-019-2687-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":28,"journal-issue":{"issue":"S4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2687"],"URL":"https:\/\/doi.org\/10.1186\/s12859-019-2687-7","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"18 April 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. The study was approved by the ethical committee of the Center of novel medical technologies in Novosibirsk (protocol N.18 from 24.10.2014). Informed consent was obtained from all patients for being included in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AK, PS, JK, OK and EW are employees of geneXplain GmbH, which maintains and distributes the geneXplain platform and My-Genome-Engancer.com used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"119"}}